Several months ago, the State Council began to work on setting up the pilot Beijing MAH system for medical devices. Shanghai, Shenzhen and Tianjin have already set up their own pilot MAH systems in 2017 and 2018. Prior to the implementation of... Read More
Beginning to put teeth to its promise of increased scrutiny of how medical devices are manufactured and sold, the Chinese government in April began requiring device firms to submit internal audits to regional regulators. The new requirement issued by the National Medical... Read More
As the number of diabetes patients continues to rise in China, so does the prevalence of end-stage kidney disease—and the demand for dialysis treatment. According to a report released in April by the National Institute of Health Data Science at Peking University,... Read More
Seeking to encourage pharmaceutical companies to market urgently needed new drugs already approved in the United States, China’s National Medical Products Administration (NMPA) is waiving the requirement for clinical trials on 30 such therapies. The list published by the NMPA on March... Read More
China is expected to update its list of medicines covered by government medical insurance plans in June, dropping some drugs with low clinical value for innovative treatments that are urgently needed. Authorities are also likely to adjust the prices it pays manufacturers... Read More
This article was originally published on MedTech Intelligence. Driven by rising obesity, lack of exercise and excessive alcohol use, heart disease has become a major health threat in China. That is propelling a need for more diagnostic tests, new devices to treat... Read More
Moving to address a chronic shortage of drug treatments for cancer patients, Chinese health authorities in February announced several new policies to bring urgently needed cancer pharmaceuticals to market. The National Medical Products Administration and the National Health Commission will make it... Read More
Responding to international outcry after a Chinese scientist claimed to have helped create gene-edited babies, China has drafted a series of new regulations on gene editing. The proposed new National Health Commission rules on clinical research address gene editing, gene transfer, and... Read More
Driven by rising levels of obesity, increasingly fatty diets and heightened levels of alcoholism, heart disease has become a severe health threat in China. That is the conclusion of a new study published in the Journal of the American Medical Association, which... Read More
In its latest move to spur the availability to Chinese consumers of medicines for rare diseases and life-threatening illnesses, China is cutting taxes on some orphan drugs almost entirely. China’s State Council will cut the value-added tax (VAT) rate for some rare-disease... Read More